← FDA DRUG APPROVALS

FDA ANDA · ANDA204072

METHYLPREDNISOLONE

Sponsor: TIANJIN TIANYAO

APPLICATION
ANDA204072
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-14
LATEST ACTION
2026-04-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METHYLPREDNISOLONEPrescription
METHYLPREDNISOLONE 4MG · TABLET · ORAL

Approval history

2026-04-10Labeling · Supplement 13 · standardAP
2024-10-11Labeling · Supplement 11 · standardAP
2024-10-11Labeling · Supplement 10 · standardAP
2018-05-14UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →